Keywords: Columbia Labs, Watson Pharma, Crinone, Preerm birth, Progesterone vaginal gel, USA, FDA

FDA Advisory thumbs down for Columbia and Watson product

Article | 23 January 2012

Print This

US drugmakers Columbia Laboratories (Nasdaq: CBRX) and Watson Pharmaceuticals (NYSE: WPI) confirmed on Friday that the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in